These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6742664)

  • 1. Estrogens and calcitonin in postmenopausal women with hyperparathyroidism.
    Gutman J; Adler RA
    Ann Intern Med; 1984 Aug; 101(2):283. PubMed ID: 6742664
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens.
    Stevenson JC; Abeyasekera G; Hillyard CJ; Phang KG; MacIntyre I; Campbell S; Townsend PT; Young O; Whitehead MI
    Lancet; 1981 Mar; 1(8222):693-5. PubMed ID: 6110915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is estrogen preferable to surgery for postmenopausal women with primary hyperparathyroidism?
    Coe FL; Favus MJ; Parks JH
    N Engl J Med; 1986 Jun; 314(23):1508-9. PubMed ID: 3702965
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma calcitonin in primary and secondary hyperparathyroidism.
    Mazzuoli GF; Coen G; Antonozzi I; Baschieri L
    Isr J Med Sci; 1971 Mar; 7(3):370. PubMed ID: 5567479
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of intravenous calcium load on serum calcitonin levels in postmenopausal osteoporotic women].
    Zséli J; Szücs J; Steczek K; Szathmári M; Kollin E; Horváth C; Guoth M; Holló I
    Orv Hetil; 1985 Mar; 126(13):771-3. PubMed ID: 3991169
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of endogenous calcitonin in postmenopausal osteoporosis].
    Body JJ; Mandart G; Struelens M; Heath H; Borkowski A
    Rev Med Brux; 1987; 8(6-7):325-8. PubMed ID: 3671923
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment with oestrogens of primary hyperparathyroidism in post-menopausal women.
    Dequeker J
    Lancet; 1972 Apr; 1(7753):747. PubMed ID: 4111219
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcitonin and estrogens.
    Agnusdei D; Civitelli R; Camporeale A; Gennari C
    J Endocrinol Invest; 1990 Sep; 13(8):625-30. PubMed ID: 2273204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal and stimulated calcitonin secretion in primary hyperparathyroidism before and after parathyroidectomy.
    Tabolli S; Valtorta C; Bigi F; Minisola S; Mazzuoli GF
    Horm Res; 1986; 23(3):142-6. PubMed ID: 3949287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre- and postoperative studies of plasma calcitonin in primary hyperparathyroidism.
    Lambert PW; Heath H; Sizemore GW
    J Clin Invest; 1979 Apr; 63(4):602-8. PubMed ID: 438324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of estrogens and calcium on calcitonin secretion in postmenopausal women.
    Body JJ; Struelens M; Borkowski A; Mandart G
    J Clin Endocrinol Metab; 1989 Jan; 68(1):223-6. PubMed ID: 2909552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing osteoporosis: the new significance of hyperparathyroidism.
    Avioli LV
    Geriatrics; 1986 Oct; 41(10):30-7. PubMed ID: 3758680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation of plasma immunoreactive parathyroid hormone and calcitonin in normal and hyperparathyroid man during daylight hours.
    Robinson MF; Body JJ; Offord KP; Heath H
    J Clin Endocrinol Metab; 1982 Sep; 55(3):538-44. PubMed ID: 7201476
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of acute estrogenic withdrawal on blood calcitonin.
    Pansini F; Bettocchi S; Bergamini C; Bianchi A; Ambrosecchia R; Bagni B; Mollica G
    Gynecol Obstet Invest; 1984; 18(1):21-6. PubMed ID: 6430757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of estrogens and related compounds in the management of primary hyperparathyroidism.
    Marcus R
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N146-9. PubMed ID: 12412792
    [No Abstract]   [Full Text] [Related]  

  • 16. Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study.
    Kiel DP; Felson DT; Anderson JJ; Wilson PW; Moskowitz MA
    N Engl J Med; 1987 Nov; 317(19):1169-74. PubMed ID: 3657888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 1980 May; 22(11):45-6. PubMed ID: 7374621
    [No Abstract]   [Full Text] [Related]  

  • 18. The activity of the bone isoenzyme of serum alkaline phosphatase and urinary hydroxyproline excretion in premenopausal and postmenopausal women with primary hyperparathyroidism.
    Broulik PD; Stĕpán J; Pacovský V
    Exp Clin Endocrinol; 1984 May; 83(3):315-9. PubMed ID: 6540700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of postmenopausal and senile osteoporosis.
    Riggs BL
    J Ark Med Soc; 1974 Mar; 70(10):317-22. PubMed ID: 4274387
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma calcitonin levels are not lower than normal in osteoporotic women.
    Prince RL; Dick IM; Price RI
    J Clin Endocrinol Metab; 1989 Mar; 68(3):684-7. PubMed ID: 2918062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.